Abnova | Income Statement

Fiscal year is January-December. All values TWD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
463,699.00
438,112.00
451,367.00
439,826.00
470,898.00
430,198
Cost of Goods Sold (COGS) incl. D&A
231,228.00
226,168.00
239,606.00
234,883.00
261,486.00
258,486
Gross Income
232,471.00
211,944.00
211,761.00
204,943.00
209,412.00
171,712
SG&A Expense
154,771.00
147,818.00
160,687.00
156,423.00
150,423.00
151,555
EBIT
77,700.00
64,126.00
51,074.00
48,520.00
58,989.00
20,157
Unusual Expense
-
-
738.00
8.00
-
-
Non Operating Income/Expense
5,540.00
6,928.00
940.00
6,854.00
11,438.00
16,790
Interest Expense
-
-
-
-
29.00
-
Pretax Income
88,692.00
77,597.00
55,618.00
57,178.00
71,739.00
37,602
Income Tax
15,599.00
11,753.00
10,536.00
3,490.00
13,908.00
9,012
Equity in Affiliates
197.00
201.00
171.00
149.00
1,135.00
496
Consolidated Net Income
72,896.00
65,643.00
44,911.00
53,539.00
58,966.00
46,118
Net Income
72,896.00
65,643.00
44,911.00
53,539.00
58,966.00
46,118
Net Income After Extraordinaries
72,896.00
65,643.00
44,911.00
53,539.00
58,966.00
46,118
Net Income Available to Common
72,896.00
65,643.00
44,911.00
53,539.00
58,966.00
46,118
EPS (Basic)
1.17
1.05
0.74
0.88
0.97
0.76
Basic Shares Outstanding
62,118.50
62,118.50
61,121.20
60,553.70
60,554.00
60,554
EPS (Diluted)
1.17
1.06
0.73
0.88
0.97
0.76
Diluted Shares Outstanding
62,207.10
62,212.40
61,193.20
60,651.50
60,649.00
60,626
EBITDA
117,027.00
101,781.00
87,261.00
84,312.00
95,484.00
61,083
Non-Operating Interest Income
5,452.00
6,543.00
4,342.00
1,812.00
1,341.00
655

About Abnova

View Profile
Address
108 Jhouzih Street
Taipei TP 114
Taiwan
Employees -
Website http://www.abnova.com.tw
Updated 07/08/2019
Abnova Taiwan Corp. is engaged in researching, developing, manufacturing and selling antibodies. It also supplies medicines and human genes albumen. Its products include antibodies for virus, microbial, neuroscience and others.